Finn Guo: Driving a New Era of Accessible Gene Therapy for Hemophilia in China
Finn Guo, Director of Information Research at Illness Challenge Foundation, shared on LinkedIn:
”From launching the project in March to completing the research report ‘Payment Mechanism and Global Strategies for Innovative Hemophilia Therapies’ in June — officially presented at the International Hemophilia Conference.
We started with patient surveys to truly understand the challenges, drew insights from international best practices, and finally developed practical solution frameworks.
While the scheme is still a long way from real-world implementation, I’m truly excited that the rapid progress in China’s domestic gene therapy for hemophilia — combined with current market pricing — is set to usher China into a new era of accessible gene therapy.
Hope is on the horizon.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome